medigraphic.com
Colegio de Medicina Interna de México.

2018, Número 3

<< Anterior Siguiente >>

Med Int Mex 2018; 34 (3)


Biología molecular del virus de la hepatitis C

Dueñas-Carrera S, Acosta-Rivero N, Morales-Grillo J, García-Ferrera WO

Idioma: Español
Referencias bibliográficas: 47
Paginas: 435-442
Archivo PDF: 434.92 Kb.


RESUMEN

La infección por el virus de la hepatitis C (VHC) se distribuye en todo el mundo, frecuentemente se convierte en hepatitis crónica, cirrosis y hepatocarcinoma. El genoma del VHC es una molécula de ARN monocatenario, de polaridad positiva, de aproximadamente 9.6 kb de longitud. Esta revisión resume el conocimiento actual y los avances recientes en la investigación de la biología molecular del VHC.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Mayo MA, Pringle CR. Virus taxonomy 1997. J Gen Virol 1998;79(Pt 4):649-657.

  2. Feinstone SM, Mihalik KB, Kimimura T, Alter HJ, London WT y Purcell RH. Inactivation of hepatitis C virus and non-A, non-B hepatitis by chloroform. Infect Immunol 1993;41:816-821.

  3. Takahashi K, Kishimoto S, Yoshizawa H, Okamoto H, Yoshikawa A y Mishiro S. p26 protein and 33 nm particle associated with nucleocapsid of hepatitis C virus recovered from the circulation of infected hosts. Virology 1992;191:431-434.

  4. Prince AM, Huima-Byron T, Parker TS y Levine DM. Visualization of Hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins. J Virol Hepatitis 1996;3:11-17.

  5. Shimizu YK, Feinstones SM, Kohara M, Purcell RH y Yoshikura H. Hepatitis C Virus: Detection of intracellular virus particles by electron microscopy. Hepatology 1996;23:205-209.

  6. Bukh J, Purcell RH y Miller RH. Sequence analysis of the 5’ noncoding region of hepatitis C virus. Proc Natl Acad Sci USA 1992;89(11):4942-4946.

  7. Honda M, Ping L-H, Rijnbrand RCA, Amphlett E, Clarke B, Rowlands DT y Lemon SM. Structural requirements for initiation of translation by internal ribosome entry within genome-lengh hepatitis C virus RNA. Virology 1996;22:31-42.

  8. Manabe S, Fuke I, Tanishita O, Kaji C, Gomi Y, Yoshida S, Mori C, Takamizawa A, Yosida I, Okayama H. Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3. Virology 1994;198(2):636-644.

  9. Takamizawa A, Mori C, Fuke I, Manabe S, et al. Structure and organization of the hepatitis C virus genome isolate from human carriers. J Virol 1991;65:1105-1113.

  10. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995;15(1):41-63.

  11. Santolini E, Migliaccio G, La monica N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol 1994;68:3631-3641.

  12. Lo S-Y, Masiarz F, Hwang SB, Lai MMC, Ou J-H. Differential subcellular localization of hepatitis C virus core gene products. Virology 1995;213:455-461.

  13. Acosta-Rivero N, Alvarez-Obregon JC, Musacchio A, Falcon V, Dueñas-Carrera S, Marante J, Menendez I, Morales J. In vitro self-assembled HCV core virus-like particles induce a strong antibody immune response in sheep. Biochem Biophys Res Commun 2002;290(1):300-4.

  14. Acosta-Rivero N, Rodriguez A, Musacchio A, Falcon V, Suarez VM, Martinez G, Guerra I, Paz-Lago D, Morera Y, de la Rosa MC, Morales-Grillo J, Dueñas-Carrera S. In vitro assembly into virus-like particles is an intrinsic quality of Pichia pastoris derived HCV core protein. Biochem Biophys Res Commun 2004;325(1):68-74.

  15. Acosta-Rivero N, Rodriguez A, Mussachio A, Poutu J, et al. A C-terminal truncated hepatitis C virus core protein variant assembles in vitro into virus-like particles in the absence of structured nucleic acids. Biochem Biophys Res Commun 2005;334(3):901-6.

  16. Chang SC, Yen J-H, Kang H-Y, Jang M-H, Chang M-F. Nuclear localization signals in the core protein of hepatitis C virus. Biochem Biophys Res Commun 1994;205(2):1284-1290.

  17. Hwang SB, Lo S-Y, Ou J-H, Lai MMC. Detection of cellular proteins and viral core protein interacting with the 5' untranslated region of hepatitis C virus RNA. J Biomed Sci 1995;2:227-236.

  18. Reed KE, Rince MC. Molecular characterization of hepatitis C virus in hepatitis C virus, Reesink HW (ed). Curr Stud Hematol Blood Transf Basel, Karger 1998;2:1-37.

  19. Acosta-Rivero N, Rodriguez A, Musacchio A, Falcon V, Suarez VM, Chavez L, Morales-Grillo J, Dueñas-Carrera S. Nucleic acid binding properties and intermediates of HCV core protein multimerization in Pichia pastoris. Biochem Biophys Res Commun 2004;323(3):926-31.

  20. Matsumoto M, Hwang SB, Jeng K-S, Zhu N, Lai MMC. Homotypic interaction and multimerization of hepatitis C core protein. Virology 1996;218:43-51.

  21. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998;4:1065-7.

  22. Marusawa H, Hijikata M, Chiba T, Shimotohno K. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol 1999;73:4713-20.

  23. Kittlesen DJ, Chianese-Bullock KA, Yao ZQ, Braciale TJ, Hahn YS. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest 2000;106: 1239-49.

  24. Fournillier A, Cahour A, Escriou N, Girard M, Wychowski C. Processing of the E1 glycoprotein of hepatitis C virus expressed in mammalian cells. J Gen Virol 1996;77:1055- 1064.

  25. Kato N. Molecular virology of hepatitis C virus. Acta Med Okayama 2001;55(3):133-159.

  26. Griffin S, Clarke D, McCormick C, Rowlands D, Harris M. Signal peptide cleavage and internal targeting signals direct the hepatitis C virus p7 protein to distinct intracellular membranes. J Virol 2005;79(24):15525-36.

  27. Rosa D, Campagnoli S, Moretto C, Guenzi E, et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci USA 1996;93:1759-1763.

  28. Gorbalenya AE, Snijder EJ. Viral cysteine proteinases. Persp Drug Discov Des 1996;6:64-86.

  29. Steinkühleer C, Tomei L, De Francesco R. In vitro activity of hepatitis C virus NS3 purified from recombinant baculovirus- infected Sf9 cells. J Biol Chem 1996;271:6367-6373.

  30. Kiiver K, Merits A, Ustav M, Zusinaite E. Complex formation between hepatitis C virus NS2 and NS3 proteins. Virus Res. 2005. Publicación electrónica antes de impresión.

  31. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis 1b. J Clin Invest 1995;96:224-230.

  32. Kato N. Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation. Microb Comp Genomics 2000;5(3):129-151.

  33. Hwang SB, Park K-J, Kim Y-S, Syng YC, Lai MMC. Hepatitis C virus NS5 B protein is a membrane associated phosphoprotein with a predominantly perinuclear localization. Virology 1997;227:439-446.

  34. Hamamoto I, Nishimura Y, Okamoto T, Aizaki H, et al. Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. J Virol 2005;79(21):13473-82.

  35. Naka K, Dansako H, Kobayashi N, Ikeda M, Kato N. Hepatitis C virus NS5B delays cell cycle progression by inducing interferon-beta via Toll-like receptor 3 signaling pathway without replicating viral genomes. Virology 2005. Publicación electrónica antes de impression.

  36. Bartenschlager R, Lohmann V. Replication of the hepatitis C virus. Baillieres Best Pract Res Clin Gastroenterol 2000;14(2):241-254.

  37. Simmonds P, Bukh J, Combet C, Deleage G, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005;42(4):962-73.

  38. Zeuzem S. The kinetics of hepatitis C virus infection. Clin Liver Dis 2001;5(4):917-930.

  39. Abe K, Inchauspe G, Fijisawa K. Genomic characterization and mutation rate of hepatitis C virus in patients who contracted hepatitis during an epidemic of NANBH in Japan. J Gen Virol 1992;73:2725-2729.

  40. Alfonso V, Mbayed VA, Sookoian S, Campos RH. Intra-host evolutionary dynamics of hepatitis C virus E2 in treated patients. J Gen Virol 2005;86(Pt 10):2781-6.

  41. Lamelin JP, Zoulim F, Trépo C. Lymphotropism of hepatitis B and C viruses: an update and a newcomor. Int J Clin Lab Res 1995;25:1-6.

  42. Zignego AL, De Carli M, Monti M, Careccia G, et al. Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. J Med Virol 1995;47:58-64.

  43. Pileri P, Uematsu Y, Campagnoli S, Galli G, et al. Binding of hepatitis C virus to CD81. Science 1998;282:938-941.

  44. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX. Hepatitis C virus and other flaviviridae viruses enter cells via low-density lipoprotein receptor. Proc Natl Acad Sci USA 1999;96(22):12766-12771.

  45. Lindenbach BD, Rice CM. Unravelling hepatitis C virus replication from genome to function. Nature 2005;436:933- 938.

  46. Blanchard E, Brand D, Trassard S, Goudeau A, Roingeard P. Hepatitis C virus-like particle morphogenesis. J Virol 2002;76(8):4073-4079.

  47. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, et al. Interferon alfa 2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485-1492.




2020     |     www.medigraphic.com